SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 21, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2015 financial results before...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 10, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA), as part of the...
10 Mar 2015
FDA Approves Unituxin™ (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 10, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved...
25 Feb 2015
United Therapeutics Corporation To Present At The Cowen And Company 35th Annual Healthcare Conference
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of...
24 Feb 2015
United Therapeutics Corporation Reports 2014 Fourth Quarter And Annual Financial Results
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2014 financial results...
06 Jan 2015
United Therapeutics Corporation To Present At 33rd Annual J.P. Morgan Healthcare Conference
SILVER SPRING, Md., Jan. 6, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer, and Roger Jeffs, Ph.D., President...
SILVER SPRING, Md., Dec. 31, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the signing of an agreement with DEKA Research & Development Corp. for the development of a potential...
SILVER SPRING, Md., Dec. 24, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug...
17 Dec 2014
United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change
SILVER SPRING, Md., Dec. 17, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today two senior executive promotions as well as changes to Martine Rothblatt, Ph.D's compensation program.Senior...
13 Nov 2014
Professor Katherine J. Klein Joins The United Therapeutics Corporation Board Of Directors
SILVER SPRING, Md., Nov. 13, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Professor Katherine J. Klein, Ph.D., of The Wharton School of the University of...
SILVER SPRING, Md., Oct. 28, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2014."We are pleased with our overall core...